For Providers

How to Refer a Patient

Referrals are welcome from psychiatric providers, therapists, primary care providers, and other medical professionals.

Please fax referrals to: 423-523-0848 

We aim to respond to referrals within 3 business days.

Outpatient Referral Form
Spravato® Referral Form

Spravato® Indications & Contraindications

Spravato® (esketamine) is FDA-approved for adults with treatment-resistant depression. Indications include:

  • Diagnosis of Major Depressive Disorder (MDD)

  • Inadequate response to at least two different antidepressants

  • Ability to safely attend in-office monitoring appointments twice per week initially

Spravato may not be appropriate for patients with:

  • Aneurysmal vascular disease

  • History of intracerebral hemorrhage

  • Unmanaged substance use disorder

  • Active psychosis

  • Unstable cardiovascular conditions

If you’re unsure, feel free to consult with us—we’re happy to collaborate on clinical appropriateness.

Accepted Insurances

NeuroBloom is accepting new self-pay patients.

We are in the process of credentialing with most major insurance plans. This page will be updated regularly so you’ll know when we are officially in-network.

Credentialing applications are in for Aetna, BCBS, Cigna/Evernorth, UHC/Optum, Humana, Wellpoint, Ambetter, and Bluecare.